Unknown Manufacturer
A synthetic decapeptide, water-soluble Gonadotropin-releasing hormone antagonist. It has reached phase II clinical trials.
A synthetic decapeptide, water-soluble Gonadotropin-releasing hormone antagonist. It has reached phase II clinical trials.
Teverelix is a GnRH (Gonadotropin releasing hormone) antagonist.
Investigated for use/treatment in benign prostatic hyperplasia, endometriosis, and prostate cancer.
